213 related articles for article (PubMed ID: 27974211)
21. Reduced hepatic lipid content in Pten-haplodeficient mice because of enhanced AKT2/PKBβ activation in skeletal muscle.
Schultze SM; Dietrich M; Hynx D; Geier A; Niessen M; Spinas GA; Hemmings BA; Tschopp O
Liver Int; 2015 Apr; 35(4):1354-66. PubMed ID: 24845341
[TBL] [Abstract][Full Text] [Related]
22. Loss of PTEN causes SHP2 activation, making lung cancer cells unresponsive to IFN-γ.
Chen CL; Chiang TH; Tseng PC; Wang YC; Lin CF
Biochem Biophys Res Commun; 2015 Oct; 466(3):578-84. PubMed ID: 26385178
[TBL] [Abstract][Full Text] [Related]
23. Alcoholic hepatitis versus non-alcoholic steatohepatitis: Levels of expression of some proteins involved in tumorigenesis.
Nguyen L; Masouminia M; Mendoza A; Samadzadeh S; Tillman B; Morgan T; French B; French S
Exp Mol Pathol; 2018 Feb; 104(1):45-49. PubMed ID: 29307797
[TBL] [Abstract][Full Text] [Related]
24. Non alcoholic steatohepatitis a precursor for hepatocellular carcinoma development.
Jiang CM; Pu CW; Hou YH; Chen Z; Alanazy M; Hebbard L
World J Gastroenterol; 2014 Nov; 20(44):16464-73. PubMed ID: 25469014
[TBL] [Abstract][Full Text] [Related]
25. Hepatocyte-specific Pten deficiency results in steatohepatitis and hepatocellular carcinomas.
Horie Y; Suzuki A; Kataoka E; Sasaki T; Hamada K; Sasaki J; Mizuno K; Hasegawa G; Kishimoto H; Iizuka M; Naito M; Enomoto K; Watanabe S; Mak TW; Nakano T
J Clin Invest; 2004 Jun; 113(12):1774-83. PubMed ID: 15199412
[TBL] [Abstract][Full Text] [Related]
26. Clinical effects of miR-101 on prognosis of hepatocellular carcinoma and carcinogenic mechanism of anti-miR-101.
Lv X; Li J; Yang B
Oncol Rep; 2016 Oct; 36(4):2184-92. PubMed ID: 27498785
[TBL] [Abstract][Full Text] [Related]
27. Probiotics suppress nonalcoholic steatohepatitis and carcinogenesis progression in hepatocyte-specific PTEN knockout mice.
Arai N; Miura K; Aizawa K; Sekiya M; Nagayama M; Sakamoto H; Maeda H; Morimoto N; Iwamoto S; Yamamoto H
Sci Rep; 2022 Sep; 12(1):16206. PubMed ID: 36171333
[TBL] [Abstract][Full Text] [Related]
28. Shp2 Deficiency in Kupffer Cells and Hepatocytes Aggravates Hepatocarcinogenesis by Recruiting Non-Kupffer Macrophages.
Du L; Ji Y; Xin B; Zhang J; Lu LC; Glass CK; Feng GS
Cell Mol Gastroenterol Hepatol; 2023; 15(6):1351-1369. PubMed ID: 36828281
[TBL] [Abstract][Full Text] [Related]
29. Mitogen-Activated Protein Kinase (MAPK) and Obesity-Related Cancer.
Donohoe F; Wilkinson M; Baxter E; Brennan DJ
Int J Mol Sci; 2020 Feb; 21(4):. PubMed ID: 32069845
[TBL] [Abstract][Full Text] [Related]
30. SHP2 acts both upstream and downstream of multiple receptor tyrosine kinases to promote basal-like and triple-negative breast cancer.
Matalkah F; Martin E; Zhao H; Agazie YM
Breast Cancer Res; 2016 Jan; 18(1):2. PubMed ID: 26728598
[TBL] [Abstract][Full Text] [Related]
31. Unique features associated with hepatic oxidative DNA damage and DNA methylation in non-alcoholic fatty liver disease.
Nishida N; Yada N; Hagiwara S; Sakurai T; Kitano M; Kudo M
J Gastroenterol Hepatol; 2016 Sep; 31(9):1646-53. PubMed ID: 26875698
[TBL] [Abstract][Full Text] [Related]
32. Elevation of liver endoplasmic reticulum stress in a modified choline-deficient l-amino acid-defined diet-fed non-alcoholic steatohepatitis mouse model.
Muraki Y; Makita Y; Yamasaki M; Amano Y; Matsuo T
Biochem Biophys Res Commun; 2017 May; 486(3):632-638. PubMed ID: 28322783
[TBL] [Abstract][Full Text] [Related]
33. PTPRO-mediated autophagy prevents hepatosteatosis and tumorigenesis.
Zhang W; Hou J; Wang X; Jiang R; Yin Y; Ji J; Deng L; Huang X; Wang K; Sun B
Oncotarget; 2015 Apr; 6(11):9420-33. PubMed ID: 25826083
[TBL] [Abstract][Full Text] [Related]
34. Transformation of SOX9
Chen J; Debebe A; Zeng N; Kopp J; He L; Sander M; Stiles BL
Sci Rep; 2021 Jun; 11(1):11823. PubMed ID: 34083580
[TBL] [Abstract][Full Text] [Related]
35. Proteome Characteristics of Non-Alcoholic Steatohepatitis Liver Tissue and Associated Hepatocellular Carcinomas.
Kakehashi A; Stefanov VE; Ishii N; Okuno T; Fujii H; Kawai K; Kawada N; Wanibuchi H
Int J Mol Sci; 2017 Feb; 18(2):. PubMed ID: 28218651
[TBL] [Abstract][Full Text] [Related]
36. Progression of non-alcoholic steatosis to steatohepatitis and fibrosis parallels cumulative accumulation of danger signals that promote inflammation and liver tumors in a high fat-cholesterol-sugar diet model in mice.
Ganz M; Bukong TN; Csak T; Saha B; Park JK; Ambade A; Kodys K; Szabo G
J Transl Med; 2015 Jun; 13():193. PubMed ID: 26077675
[TBL] [Abstract][Full Text] [Related]
37. [Hepatocyte-specific Pten deficient mice].
Horie Y; Ohshima S; Sato W; Suzuki A; Watanabe S
Nihon Rinsho; 2006 Jun; 64(6):1033-42. PubMed ID: 16768106
[TBL] [Abstract][Full Text] [Related]
38. CRISPR/Cas9-based Pten knock-out and Sleeping Beauty Transposon-mediated Nras knock-in induces hepatocellular carcinoma and hepatic lipid accumulation in mice.
Gao M; Liu D
Cancer Biol Ther; 2017 Jul; 18(7):505-512. PubMed ID: 28513320
[TBL] [Abstract][Full Text] [Related]
39. PTENα and PTENβ promote carcinogenesis through WDR5 and H3K4 trimethylation.
Shen SM; Zhang C; Ge MK; Dong SS; Xia L; He P; Zhang N; Ji Y; Yang S; Yu Y; Zheng JK; Yu JX; Xia Q; Chen GQ
Nat Cell Biol; 2019 Nov; 21(11):1436-1448. PubMed ID: 31685992
[TBL] [Abstract][Full Text] [Related]
40. Expansion of hepatic tumor progenitor cells in Pten-null mice requires liver injury and is reversed by loss of AKT2.
Galicia VA; He L; Dang H; Kanel G; Vendryes C; French BA; Zeng N; Bayan JA; Ding W; Wang KS; French S; Birnbaum MJ; Rountree CB; Stiles BL
Gastroenterology; 2010 Dec; 139(6):2170-82. PubMed ID: 20837017
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
